180 related articles for article (PubMed ID: 34570443)
1. Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer.
Huang Y; Wang H; Lyu Z; Dai H; Liu P; Zhu Y; Song F; Chen K
Cancer Biol Med; 2021 Sep; 19(9):1375-84. PubMed ID: 34570443
[TBL] [Abstract][Full Text] [Related]
2. Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis.
Yang L; Wang S; Zhang L; Sheng C; Song F; Wang P; Huang Y
BMC Cancer; 2020 Jun; 20(1):499. PubMed ID: 32487106
[TBL] [Abstract][Full Text] [Related]
3. [Accuracy and direct medical cost of different screening modalities for breast cancer among Chinese women].
Kang M; Zhao Y; Huang Y; Li J; Liu L; Li H
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):236-40. PubMed ID: 24785288
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial.
Harada-Shoji N; Suzuki A; Ishida T; Zheng YF; Narikawa-Shiono Y; Sato-Tadano A; Ohta R; Ohuchi N
JAMA Netw Open; 2021 Aug; 4(8):e2121505. PubMed ID: 34406400
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Breast Cancer Risk Predictive Models and Screening Strategies for Chinese Women.
Zhao Y; Xiong P; McCullough LE; Miller EE; Li H; Huang Y; Zhao M; Wang MJ; Kang M; Wang Q; Li JY
J Womens Health (Larchmt); 2017 Mar; 26(3):294-302. PubMed ID: 28263689
[TBL] [Abstract][Full Text] [Related]
6. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
Conant EF; Barlow WE; Herschorn SD; Weaver DL; Beaber EF; Tosteson ANA; Haas JS; Lowry KP; Stout NK; Trentham-Dietz A; diFlorio-Alexander RM; Li CI; Schnall MD; Onega T; Sprague BL;
JAMA Oncol; 2019 May; 5(5):635-642. PubMed ID: 30816931
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for breast cancer in women undergoing mammography.
Reuter KL; Baker SP; Krolikowski FJ
AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
[TBL] [Abstract][Full Text] [Related]
8. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
[TBL] [Abstract][Full Text] [Related]
9. Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.
Dong H; Huang Y; Song F; Dai H; Liu P; Zhu Y; Wang P; Han J; Hao X; Chen K
Clin Breast Cancer; 2018 Jun; 18(3):e353-e361. PubMed ID: 28887010
[TBL] [Abstract][Full Text] [Related]
10. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
11. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
[TBL] [Abstract][Full Text] [Related]
12. Is clinical breast examination effective in Japan? Consideration from the age-specific performance of breast cancer screening combining mammography with clinical breast examination.
Ohta K; Kasahara Y; Tanaka F; Maeda H
Breast Cancer; 2016 Mar; 23(2):183-9. PubMed ID: 24925524
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40-49 years: analysis of data from the J-START results.
Uematsu T
Breast Cancer; 2022 Sep; 29(5):928-931. PubMed ID: 35507294
[TBL] [Abstract][Full Text] [Related]
14. Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women.
Huang Y; Dai H; Song F; Li H; Yan Y; Yang Z; Ye Z; Zhang S; Liu H; Cao Y; Xiong L; Luo Y; Pan T; Ma X; Wang J; Song X; Leng L; Zhang Y; Sun J; Wang J; Ma H; Kong L; Lei Z; Wang Y; Peishan W; Han J; Hao X; Chen K
Sci Rep; 2016 Dec; 6():39459. PubMed ID: 27995968
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer screening and early diagnosis in China: a systematic review and meta-analysis on 10.72 million women.
Li M; Wang H; Qu N; Piao H; Zhu B
BMC Womens Health; 2024 Feb; 24(1):97. PubMed ID: 38321439
[TBL] [Abstract][Full Text] [Related]
16. Combined performance of physical examination, mammography, and ultrasonography for breast cancer screening among Chinese women: a follow-up study.
Huang Y; Kang M; Li H; Li JY; Zhang JY; Liu LH; Liu XT; Zhao Y; Wang Q; Li CC; Lee H
Curr Oncol; 2012 Jul; 19(Suppl 2):eS22-30. PubMed ID: 22876165
[TBL] [Abstract][Full Text] [Related]
17. Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
Chiarelli AM; Blackmore KM; Muradali D; Done SJ; Majpruz V; Weerasinghe A; Mirea L; Eisen A; Rabeneck L; Warner E
J Natl Cancer Inst; 2020 Feb; 112(2):136-144. PubMed ID: 31233143
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening.
Mital S; Nguyen HV
BMC Cancer; 2022 May; 22(1):501. PubMed ID: 35524200
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit.
Maurice A; Evans DG; Affen J; Greenhalgh R; Duffy SW; Howell A
Int J Cancer; 2012 Jul; 131(2):417-25. PubMed ID: 21898384
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
